.jpeg)
Gene by Gene becomes one ofUltima Genomics' Certified Service Providers, alongside the University of Minnesota Genome Center and the New York Genome Center. Gene by Gene will thus be able to offer its customers all over the world, such as the University of Glasgow or the MD Anderson Center in Texas, full genome sequencing (reading and decoding a person's entire DNA), as well as numerous other applications based on the Ultima Genomics platform.
Thanks to Ultima Genomics' technology, it is now possible to obtain genetic analyses of exceptional quality, while considerably reducing costs. This democratization of sequencing opens the way to major applications ranging from medical diagnosis and scientific research to consumer testing and forensic investigations. Ultima Genomics has already assisted and supported several renowned institutions, including Broad Clinical Labs and the Ontario Institute for Cancer Research. This network illustrates the company's ambition: to give everyone, researchers and doctors alike, access to a high-performance, affordable sequencing tool. Ultima Genomics has also been commissioned to carry out the largest-ever study of human proteins.
This momentum is underpinned by constant innovation, notably the recent introduction of Solaris chemistry, which, combined with high-performance software and streamlined processes, has increased the sequencing capacity of the Ultima Genomics platform by over 50%. In concrete terms, each cycle can now generate up to 12 billion DNA reads, driving down costs even further, while speeding up the work of scientific teams. Solaris chemistry also enables an even greater reduction in costs, of around 20% per read, as well as greater precision, now making it possible to work with even smaller quantities of DNA (between 50 and 100 times less).
